Cargando…

627. Differences in C. difficile Toxin A Binding in Humans: Adults vs. Infants

BACKGROUND: Children less than 1 year of age are commonly colonized with toxin-producing C. difficile, but appear to be immune to the associated colitis. Animal studies suggest that young infants lack receptors for C. difficile toxin, though this has never been documented in humans. METHODS: Tissue...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goldman, David, Elshazly, Ahmed, Dadachova, Ekaterina, Ewart, Michelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255571/ http://dx.doi.org/10.1093/ofid/ofy210.634

Ejemplares similares

507. Degree of Concordance of Clostridium difficile Strains in Adults with Community-Associated C. difficile Infection and Infants With C. difficile Colonization
por: Clayton, Jason A, et al.
Publicado: (2018)

627. Tele-OPAT Outcomes at Two Community Hospitals
por: Sheridan, Kathleen R, et al.
Publicado: (2020)

2366. PCR Followed by Toxin EIA for the Diagnosis of C. difficile Infection
por: Zhang, Yu, et al.
Publicado: (2019)

Enzyme Immunoassay for C. difficile Toxin Reduces Lab ID Events but Fails to Detect Clinically Significant C. difficile Infection
por: Ridgway, Jessica P, et al.
Publicado: (2017)

PT627. Effect of Antidepressant Treatment on BDNF concentrations in Patients with Somatization Disorders
por: Yang, Jong-Chul, et al.
Publicado: (2016)

627. Molecular Epidemiology of Daptomycin-resistant Staphylococcus aureus Causing Bloodstream Infections
por: Gudipati, Smitha, et al.
Publicado: (2019)

839. Effect of Clostridioides difficile (C. difficile) Toxin Test Reporting on Clinical Treatment and Outcomes of Toxin-Negative PCR-Positive Patients at Five California Hospitals
por: Polage, Christopher R, et al.
Publicado: (2019)

Another surprise in receptor binding of C. difficile toxins
por: Aktories, Klaus
Publicado: (2022)

135. Impact of Clostridioides difficile Toxin Confirmation on Subsequent C. difficile Treatment in a Rural Health System (IT-CDI)
por: Crawford, Jacquelyn, et al.
Publicado: (2023)

Endogenous Serum IgG Antibodies to Clostridium difficile Toxin B Are Associated with Protection against C. difficile Infection Recurrence
por: Kelly, Ciaran P, et al.
Publicado: (2017)

Clinical Characteristics and Outcomes of Hematologic Malignancy Patients with Clostridium difficile Toxin EIA vs. PCR Positive Test Results
por: Ziegler, Matthew, et al.
Publicado: (2017)

787. Evaluation of Clostridioides difficile Environmental Contamination Surrounding C. difficile Patients vs. non-C. difficile Patients in Outpatient Infusion Centers
por: Garey, Kevin W, et al.
Publicado: (2020)

532. Recurrent C. difficile in Children: Not Easy to Cure
por: Lee, Philip, et al.
Publicado: (2018)

1092. Tuning Down Clostridioides difficile PCR Sensitivity Reduces Treatment for C. difficile Infection in Toxin-Negative Patients With No Increase in Adverse Outcomes
por: Hitchcock, Matthew, et al.
Publicado: (2018)

627. Bioinformatic Approach to Design a Plasmodium falciparum PfRipr Multi-Epitope Vaccine Construct
por: Laurenson, Alexander J, et al.
Publicado: (2023)

976. Clostridium difficile Colonization Molecular Epidemiology and Anti-toxin Serological Responses in Healthy Infants: A Prospective Cohort Study
por: Kociolek, Larry, et al.
Publicado: (2018)

CD4+ T Cells Specific for C. difficile Toxins are a Marker of Patients with Active Relapsing Disease
por: Cook, Laura, et al.
Publicado: (2017)

781. C.difficile PCR+/ Toxin EIA- treat or not treat? A clinician survey
por: Nath, Sarath G, et al.
Publicado: (2020)

677. To Treat or Not To Treat: Patients with Clostridioides difficile PCR-positive/Toxin EIA negative Test Results
por: Yang, Krista, et al.
Publicado: (2023)

Binding and neutralization of C. difficile toxins A and B by purified clinoptilolite-tuff
por: Ranftler, Carmen, et al.
Publicado: (2021)

671. Introduction of simultaneous Clostridioides difficile Antigen and Toxin A and B detection for diagnosis of C. difficile related diarrhea at Michael E. DeBakey VA Medical Center
por: Ashley, Patrycja, et al.
Publicado: (2023)

1089. Analytical Performance of an Ultrasensitive Immunoassay for Detection of Clostridium difficile Toxins in Stool
por: Bartolome, Amelita, et al.
Publicado: (2018)

2398. Effect of Eosinopenia and Binary Toxin on Clostridioides difficile Infection Clinical Outcomes
por: Carlson, Travis J, et al.
Publicado: (2019)

386. Clostridioides difficile PCR Cycle Threshold to Determine Toxin Positivity Status
por: Crone, Andrew S, et al.
Publicado: (2022)

627. CURE ID as a Tool for Curating and Analyzing Drugs Used in COVID-19 Clinical Trials
por: Charles, Reema, et al.
Publicado: (2021)

NMR spectra of PB2 627, the RNA-binding domain in influenza A virus RNA polymerase that contains the pathogenicity factor lysine 627, and improvement of the spectra by small osmolytes
por: Kato, Yusuke S., et al.
Publicado: (2017)

On and Off: A Dual Role for Cysteine Protease Autoprocessing of C difficile Toxin B on Cytotoxicity vs Proinflammatory Toxin Actions?
por: Chen, Xinhua, et al.
Publicado: (2018)

2435. The Impact of Treatment Strategy and Toxin Status on Outcomes of Patients with Clostridioides difficile Infections
por: Friedman, Daniel, et al.
Publicado: (2019)

Spore Formation and Toxin Production in Clostridium difficile Biofilms
por: Semenyuk, Ekaterina G., et al.
Publicado: (2014)

1982. A Diagnostic Stewardship Intervention for Clostridioides difficile: Impact of Stool Toxin Testing on Treatment of Adult Inpatients
por: Moss, Jason, et al.
Publicado: (2019)

SUN-627 Unexpected Presentation of a Primary Thyroid T-Cell Lymphoma
por: Vergne-Santiago, Norma, et al.
Publicado: (2019)

707. Molecular Epidemiology of Clostridioides difficile Colonization in Families with Infants
por: Toltzis, Philip, et al.
Publicado: (2023)

PCR Cycle-Threshold-Derived Toxin Identifies Patients at Low-Risk for Complications of C. difficile Infection Who Do Not Require Treatment
por: Hitchcock, Matthew, et al.
Publicado: (2017)

Transmission of Influenza Virus in a Mammalian Host Is Increased by PB2 Amino Acids 627K or 627E/701N
por: Steel, John, et al.
Publicado: (2009)

487. Severity and Clinical Outcomes of Clostridium difficile Infection Based on Toxin B Assay Results
por: Kamimoto, Jorge Jo, et al.
Publicado: (2018)

1093. Single Molecule Counting Technology for Ultrasensitive Quantification of Clostridium difficile Toxins A and B
por: Katzenbach, Phoebe, et al.
Publicado: (2018)

2379. It’s Getting Complicated: Outcomes of Clostridiodes difficile PCR Positive/Toxin-Negative Patients
por: Morillas, Jose A, et al.
Publicado: (2019)

683. Understanding Clostridioides difficile toxinB gene conservation through surveillance of public data
por: Mulholland, Kelly, et al.
Publicado: (2023)

126 An Optimized, Synthetic DNA Vaccine Encoding the Toxin A and Toxin B Receptor Binding Domains of Clostridium difficile Induces Protective Antibody Responses In Vivo
por: Kutzler, Michele
Publicado: (2014)

IS627: Radiotracer diﬀusion in refractory high-entropy alloys
por: Divinski, S V
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_eb726c9djmu8sinqo02fgljf9d